Tina Marriott - Feb 4, 2022 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Signature
/s/ Nathan Hatfield, attorney-in-fact
Stock symbol
RXRX
Transactions as of
Feb 4, 2022
Transactions value $
-$9,439
Form type
4
Date filed
2/8/2022, 08:05 PM
Previous filing
Dec 20, 2021
Next filing
Feb 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Award $0 +79.6K +164.69% $0.00 128K Feb 4, 2022 Direct F1, F2
transaction RXRX Class A Common Stock Award $0 +2.39K +1.87% $0.00 130K Feb 4, 2022 Direct F3
transaction RXRX Class A Common Stock Tax liability -$9.44K -828 -0.64% $11.40 130K Feb 4, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RXRX Stock Option (Right to Buy) Award $0 +159K $0.00 159K Feb 4, 2022 Class A Common Stock 159K $11.40 Direct F4
transaction RXRX Stock Option (Right to Buy) Award $0 +4.78K $0.00 4.78K Feb 4, 2022 Class A Common Stock 4.78K $11.40 Direct
holding RXRX Stock Option (Right to Buy) 713K Feb 4, 2022 Class A Common Stock 713K $1.06 Direct F5
holding RXRX Stock Option (Right to Buy) 150K Feb 4, 2022 Class A Common Stock 150K $2.47 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on May 15, 2022 and every three months thereafter.
F2 Includes 841 shares purchased pursuant to the Issuer's Employee Stock Purchase Plan on November 22, 2021.
F3 This RSU vested immediately upon the grant date.
F4 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
F5 Twenty-Five percent (25%) of the shares subject to the award shall vest one year after July 16, 2018, or the Annual Vesting Commencement Date, and one-forty-eighth (148th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Annual Vesting Commencement Date.
F6 One forty-eighth (1/48th) of the shares subject to the award shall vest one month after December 31, 2020, or the Monthly Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Monthly Vesting Commencement Date.